Skip to main content
Premium Trial:

Request an Annual Quote

J. Craig Venter, Deborah Smeltzer, Avril Hamilton, Krish Sakhamuru, Kary Mullis

Premium
J. Craig Venter has stepped down from the board of directors of US Genomics, the company said last week. He is replaced by Salvatore Salamone, who is chairman and CEO of Saladax Biomedical and was formerly vice president of R&D at Roche Diagnostics.
 

 
ExonHit Therapeutics has appointed Deborah Smeltzer to its supervisory board. Smeltzer is CFO and vice president of operations at Dynavax Technologies. She formerly was vice president and general manager of Applied Biosystems’ genetic-analysis business.
 

 
MWG Biotech has tapped Avril Hamilton for the post of UK and Ireland sales manager, and hired Krish Sakhamuru to be the key account salesperson. 
 
Before joining MWG, Hamilton was senior European territory manager at Cogenics and was in sales at PerkinElmer and Bio-Rad.
 
Sakhamuru was an account manager with Elsevier MDL and Informax.
 

 
Kary Mullis has joined Insight Medical Group’s board of advisors. Mullis received the Nobel Prize in chemistry in 1993 for inventing PCR. He is currently a distinguished researcher at Children's Hospital and Research Institute in Oakland, Calif.
 

The Scan

Booster Push

New data shows a decline in SARS-CoV-2 vaccine efficacy over time, which the New York Times says Pfizer is using to argue its case for a booster, even as the lower efficacy remains high.

With Help from Mr. Fluffington, PurrhD

Cats could make good study animals for genetic research, the University of Missouri's Leslie Lyons tells the Atlantic.

Man Charged With Threatening to Harm Fauci, Collins

The Hill reports that Thomas Patrick Connally, Jr., was charged with making threats against federal officials.

Nature Papers Present Approach to Find Natural Products, Method to ID Cancer Driver Mutations, More

In Nature this week: combination of cryogenic electron microscopy with genome mining helps uncover natural products, driver mutations in cancer, and more.